KatherineYvonneLookMD

PubMed

• 339 citations
  Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncolog...
  Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson, Helen Huang, Lois M. Ramondetta, Lisa M. Landrum, Ana Oaknin, Thomas J. Reid, Mario M. Leitao, Helen Michael,...> ;Lancet. 2017 Oct 7
• 13 citations
  A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer
  Jalid Sehouli, Ana Maria Alvarez, Shokoufeh Manouchehrpour, Prafull Ghatage, Cezary Szczylik, Annamaria Zimmermann, Thomas Bauknecht, Katherine Look, Gultan Oskay-Öezc...> ;Gynecologic Oncology. 2012 Feb 1
• 9 citations
  A phase I trial of pemetrexed plus carboplatin in recurrent ovarian cancer
  Jalid Sehouli, Oumar Camara, Sven Mahner, Thomas Bauknecht, Werner Lichtenegger, Ingo B. Runnebaum, Katherine Look, Fritz Jaenicke, Guelten Oskay-Oezcelik> ;Cancer Chemotherapy and Pharmacology. 2010 Jan 7
• 3 citations
  Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: The India...
  Achilles J. Fakiris, Mark A. Henderson, Simon S. Lo, Katherine Y. Look, Higinia R. Cardenes> ;Brachytherapy. 2010 Jan 1
• 8 citations
  Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
  Katherine Y. Look, John A. Blessing, Chad M. Michener, Stephen C. Rubin> ;International Journal of Gynecological Cancer. 2008 Jul 1
• A phase I/II study of pemetrexed in combination with carboplatin in patients with platin sensitive recurrent ovarian or peritoneal cancer (PSOC).
  Sehouli J, Kania M, Zimmerman A, Look K, Mustea A> ;J. Clin. Oncol.. 2008-05-20
• 120 citations
  Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group ...
  Jeffrey Bell, Mark F Brady, Robert C Young, Janice Lage, Joan L Walker, Katherine Y Look, G Scott Rose, Nick M Spirtos> ;Gynecologic Oncology. 2006 Sep 1
• 57 citations
  Carcinoma of the vulva.
  Frederick B. Stehman, Katherine Y. Look> ;Obstetrics and Gynecology. 2006 Mar 1
• 37 citations
  The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer
  T. S. Barlow, M. Przybylski, Jeanne M. Schilder, David H. Moore, Katherine Y. Look> ;International Journal of Gynecological Cancer. 2006 Mar 1
• 14 citations
  Obstetrics-gynecology resident satisfaction
  Bridgette A. Blazek, Terrell W. Zollinger, Katherine Y. Look> ;American Journal of Obstetrics and Gynecology. 2005 Nov 1
• 28 citations
  Phase II trial of liposomal doxorubicin at 40 mg/m2 every 4 weeks in endometrial carcinoma: A Gynecologic Oncology Group Study
  Howard D. Homesley, John A. Blessing, Joel I. Sorosky, Gary Reid, Katherine Y. Look> ;Gynecologic Oncology. 2005 Aug 1
• 28 citations
  Factors detracting students from applying for an obstetrics and gynecology residency.
  Dominique L. Gariti, Terrell W. Zollinger, Katherine Y. Look> ;American Journal of Obstetrics and Gynecology. 2005 Jul 1
• Phase II trial of liposomal doxorubicinin disseminated endometrial carcinoma: A Gynecologic Oncology Group study.
  Homesley HD, Blessing JA, Sorosky JI, Reid GC, Look KY> ;J. Clin. Oncol.. 2005-06-01
• Outcome in surgically staged papillary serous and clear cell carcinoma of the uterus: A single institution experience.
  Harris SL, Randall ME, Look KY, Moore DH, Fakiris AJ, Lo S, Cardenes H> ;J. Clin. Oncol.. 2005-06-01
• 14 citations
  Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase I...
  Achilles J. Fakiris, David H. Moore, Shailaja Reddy, Katherine Y. Look, Constantin T. Yiannoutsos, Marcus E. Randall, Higinia R. Cardenes> ;Gynecologic Oncology. 2005 Mar 1
• 379 citations
  Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study
  Gini F. Fleming, Virginia L. Brunetto, David Cella, Katherine Y. Look, Gary C. Reid, Adnan R. Munkarah, Richard Kline, Robert A. Burger, Annekathryn Goodman, R. Tucker...> ;Journal of Clinical Oncology. 2004 Jun 1
• 4 citations
  Phase II study of ifosfamide plus daily oral etoposide in previously treated ovarian cancer: a Hoosier Oncology Group (HOG) study.
  Montaser Shaheen, Michael J. Stender, J. McClean, Katherine Y. Look, Lawrence H. Einhorn> ;American Journal of Clinical Oncology. 2004 Jun 1
• 52 citations
  Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study.
  J. Tate Thigpen, John A. Blessing, Koen DeGeest, Katherine Y. Look, Howard D. Homesley> ;Gynecologic Oncology. 2004 May 1
• 110 citations
  Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study
  Katherine Y. Look, Alan Sandler, John A. Blessing, Joseph A. Lucci, Peter G. Rose> ;Gynecologic Oncology. 2004 Feb 1
• 17 citations
  Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecolo...
  Katherine Y. Look, Michael A. Bookman, Jessie Schol, Thomas J. Herzog, Thomas F. Rocereto, Jennifer Vinters> ;Gynecologic Oncology. 2004 Jan 1
• 28 citations
  The risk of nodal metastasis in early adenocarcinoma of the uterine cervix.
  J. Balega, Helen Michael, Jean A. Hurteau, David H. Moore, J. Santiesteban, G. P. Sutton, Katherine Y. Look> ;International Journal of Gynecological Cancer. 2004 Jan 1
• 15 citations
  A randomized phase II evaluation of bryostatin-1 (NSC #339555) in recurrent or persistent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group Study.
  Deborah K. Armstrong, John A. Blessing, Katherine Y. Look, Russell J. Schilder, Evelyn R. Nunez> ;Investigational New Drugs. 2003 Aug 1
• 74 citations
  Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an int...
  George A. Omura, Mark F. Brady, Katherine Y. Look, Hervy E. Averette, James E. Delmore, Harry J. Long, Scott Wadler, Gregory Spiegel, Susan G. Arbuck> ;Journal of Clinical Oncology. 2003 Aug 1
• 177 citations
  Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers
  Paul J. Goodfellow, Barbara M. Buttin, Thomas J. Herzog, Janet S. Rader, Randall K. Gibb, Elizabeth M. Swisher, Katherine Y. Look, Ken C. Walls, Ming Yu Fan, David G. ...> ;Proceedings of the National Academy of Sciences of the United States of America. 2003 May 13
• 3 citations
  Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies: A Gynecologic Oncology Group study.
  Agustin A. Garcia, Michael A. Bookman, Lorna Rodriguez-Rodriguez, David G. Mutch, Katherine Y. Look> ;Investigational New Drugs. 2002 Nov 1
• Join now to see all

Journal Articles

• A phase I study of tasisulam (LY 573636), a novel anticancer compound, administered as as a 24-hour continuous infusion in patients with advanced solid tumors  
  Gordon MS, Ilaria R, De Alwis d, Mendelson DS, McKane S, Wagner MM, Look KY, Lorusso PM, Cancer Chemo Pharmacol, 1/1/2013
• A phase II trial of Pemetrexed with Carboplatin in patients with Recurrent ovarian or primary peritoneal cancer  
  Sehouli, J, Alverez AM, Manouchhpour S, Ghatage P, Szczylik C, Zimmerman A, Bauknecht T, Look KY, Oskay-Ozcelik G, Gynecol Oncol, 1/1/2012
• Phase II Evaluation of Capecitabine Patients with Refractory Non-Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study  
  Look KY, Blessing JA, Michener CM, Rubin SC, Ramirez PT, Int J Gyn Cancer, 1/1/2008
• Clinical Expert Series: Carcinoma of the vulva  
  Stehman FB, Look KY, Obstet Gynecol, 1/1/2006
• The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer  
  Barlow TS, Przybylski M, Schilder JM, Moore DH, Look KY, Int J Gyn Cancer, 1/1/2006
• Randomized Phase Trial of Three vs Six Cycles of Adjuvant Carbolatiin and Paclitaxel in Early Stage Epithelial Ovarian Carcinoma: a Gynecologic Oncology Group study  
  Bell J, Brady MF, Young RC, Lange J, Walker JL, Look KY, Rose GS, Spirtos NM, Obstet Gynecol, 1/1/2006
• Liposomal doxorubicin has modest activity in Phase II trial of disseminated endometrial carcinoma: a Gynecologic Oncology Group study  
  Homesley HD, Blesssing JA, Sorosky J, Reid G, Look KY, Gynecol Oncol, 1/1/2005
• Obstetrics-Gynecology Resident Satisfaction  
  Blazek BA, Zollinger TW, Look KY, Am J Obstet Gynecol, 1/1/2005
• Role of Lymphadenectomy in management of adenocarcinoma of the endometrium  
  Look KY, Eur J Gyn Oncol, 1/1/2004
• Advanced Stage Endometrial Carcinoma Progress and Future Directions Feature Case Study and Commentary  
  Look KY, The American Journal of Oncology Review, 1/1/2004
• Risk of Nodal Metastasis in Early Adenocarcinoma of the Uterine Cervix  
  Balega J, Michael H, Hurteau J, Moore DH, Santiesteban J, Sutton GP, Look KY, Int J Gyn Ca, 1/1/2004
• Phase I Feasibility Trial of Carboplatin Paclitaxel, and Gemcitabine in patients with Previously Untreated Epithelial Ovarian or Primary Peritoneal Cancer: a Gynecolog...  
  Look KY, Bookman MA, Schol J, Herzog T, Rocereto T, Gynecol Oncol, 1/1/2004
• Phase II Trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group study  
  Look KY, Sandler A, Blessing JA, Lucci JA, Rose PG, Gynecol Oncol, 1/1/2004
• A Phase III Trial of doxorubicin plus cisplatin with or without paclitaxel plus filgastrim in advanced endometrial carcinoma: a Gynecologic Oncology Group study  
  Fleming GF, Brunetto VL, Cella D, Look KY, Reid G, Munkarah AR, Kline R, Burger R, Goodman A, Burks RT, J Clin Oncol, 1/1/2004
• Cisplatin as initial therapy in ovarian carcinosarcoma: a Gynecologic Oncology Group study  
  Thigpen T, Blessing JA, DeGeest K, Look KY, Homesley H, Gynecol Oncol, 1/1/2004
• A phase II study of Ifosfamide plus Oral Daily Etoposide in previously treated ovary cancer: A Hoosier Oncology Group (HOG) Study  
  Shaheen M, Stender MJ, McClean JW, Look KY, Einhorn LE, Am J Clin Oncol, 1/1/2004
• Prevalence of defective DNA mismatch repair and MSH 6 mutation in a unselected series of endometrial cancer  
  Goodfellow PJ, Buttin BM, Herzog TJ, Rader JS, Gibb RK, Swisher E, Look K, Walls KC Fan MY, Mutch DG, Proc National Acad Sciences, 1/1/2003
• Phase III Trial of Paclitaxel at two dose levels, the higher dose accompanied by filgastrim at twodose levels in platinum-pretreated epithelial ovarian cancer: an Inte...  
  Omura GA, Brady MF, Look KY, Averette HE, Delmore JE, Long HJ, Wadler S, Spiegel G, Arbuck S, J Clin Oncol, 1/1/2003
• A Randomized Phase II Evaluation of Bryostatin (NSC #339555) in Recurrent or Persistent Platinum-Senstive Ovarian Cancer: a Gynecologic Oncology Group Study  
  Amstrong DK, Blessing JA, Look KY, Schilder R, Nunez ER, Inv New Drugs, 1/1/2003
• Phase I Escalation of Gemcitabine combined with Protracted Oral Etoposide in Gynecologic Malignancies  
  Garcia AA, Bookman MA, Rodriguez-Rodriguez L, Mutch DG, Look KY, Inv New Drugs, 1/1/2002
• Review of Gynecologic Oncology: Principles & Practice of Chemotherapy (eds Deppe G & Baker V)  
  Look KY, Gynecol Oncol, 1/1/2001
• Prognostic Factors for Carcinoma of the Cervical Stump & Cervical Carcinoma associated with pregnancy  
  Boyd SC, Look KY, CME Journal of Gynecologic Oncology, 1/1/2001
• The Surveillance of the patient with epithelial ovarian cancer following Primary chemotherapy  
  McKnight E, Look KY, CME Journal of Gynecologic Oncology, 1/1/2001
• Metastatic Neuroendocrine carcinoma of the uterine Cervix coexisting with human immunodeficiency virus infection  
  Balega J, Ulbright T, Look KY, Int J Gyn Cancer, 1/1/2001
• Who benefits from radiotherapy in treatment of endometrial cancer and at What price? (editorial)  
  Look KY, Lancet, 4/22/2000
• Join now to see all

Books/Book Chapters

• Principles and Practice Radiation Oncology 
  Chapter: Chapter 67: Endometrium 
  Cardenes HC, Look KY, Michael H, Cerezo HEditors: Perez C.2006
• Principles and Practice of Gynecologic Oncology 
  Chapter: Vagina 
  Page 707 - 742Cardenes H, Roth L, McGuire W, Look KYEditors: WJ Hoskins, CA Perez, RC Young, R Barakat, M Markman and M Randall.Lippincott Williams & Wilkins, Philadelphia, PAEdition 4th,2004
• Cancer of the Female Lower Genital Tract, American Cancer Society Atlas Hamilton 
  Chapter: Management of Vaginal Cancer 
  Page 183 - 202Cardenes HC, Look KY, Randall MREditors: Eifel P, Levenback C.BC Decker Inc., Ontario, Canada2002
• Current Therapy in Cancer 
  Chapter: Carcinoma of the Cervix 
  Page 158 - 161Look KYEditors: Foley JF, Vose JM, Armitage JO.W.B. Sanders Co., Philadelphia, PAEdition 2nd,1999
• Practical Gynecology 
  Chapter: Vulvar Carcinoma and Vaginal Carcinoma 
  Page 349 - 356Look KY, Stehman FBEditors: Jacobs AJ and Gast MJ.Appleton & Lange, Norwalk, CT1994
• Current Therapy in Cancer 
  Chapter: Cervix 
  Page 125 - 128Look KYEditors: Foley JF, Vose JM, Armitage JO.W.B. Sanders Co., Philadelphia, PA1994
• A Clinical Manual of Gynecology 
  Chapter: The House Officer as Teacher, Learner and Health Team Manager 
  Page 1 - 10Barzansky BM, Beckmann CRB, Richards R, Spellacy WN, Look KYEditors: Ellis JW, Beckmann CRB.Appleton-Century Crofts, Norwalk, CT1993
• Clinical Consultations in Obstetrics and Gynecology 
  Chapter: The Role of Cytotoxic Chemotherapy in Endometrial Adenocarcinoma 
  Page 135 - 140Look KYEditors: Burke TW.W.B. Sanders Co., Philadelphia, PA1993
• Ovarian Cancer 
  Chapter: Epidemiology, Etiology and Screening of Ovarian Cancer 
  Page 175 - 187Look KYEditors: Rubin SC, Sutton GP.McGraw-Hill, NY1993
• Principles and Practice of Clinical Gynecology 
  Chapter: Endometrial Cancer and Uterine Sarcomas 
  Sutton GP, Stehman FB, Look KYEditors: Kase N, Weingold AB, Gershenson D.Churchill-Livingston, NYEdition 2nd,1990
• Join now to see all

Abstracts/Posters

• Phase II, single age arm study of tasisulam-sodium (LY573636) as 2nd-4th line therapy for platinum resistant ovarian cancer
  Gordon M, McMeeking Ds, Temkin s, Tew W, S Yapp, Scambia G, Streltsova O, Kaiser C, Ilaria R Look KY, AACRI-NCI-EORTC International conference: Molecular Targets and Cancer Therapeutics, 11/15/2009
• Phase II, single age arm study of tasisulam-sodium (LY573636) as 2nd-4th line therapy for platinum resistant ovarian cancer
  Gordon M, McMeeking Ds, Temkin s, Tew W, S Yapp, Scambia G, Streltsova O, Kaiser C, Ilaria R Look KY, Molecular Cancer Therapeutics, 1/1/2009
• A Phase I-II study of Pemetrexed in Combination with Platin Sensitive Recurrent Ovarian or Peritoneal Cancer (PSOC)
  Sehouli J, Kania M, Zimmerman A, Look K, Mustea A, ASCO, Chicago, IL, 5/30/2008
• Phase III study of gemcitabine (G) plus paclitaxel (T) versus T in patients with Metastatic Breast Cancer (MBC): Post-study chemotherapy (PSC) trend analysis (Poster D...
  Llombert A, Nag S, Calderillo-Ruiz G, Jordan J, Rolski J, Pluzanska A, Simms L, Look K, Gill J, Melemed A, O’Shaughnessy J, European Breast Cancer Conference, Berlin, Germany, 4/15/2008
• Phase II, single age arm study of tasisulam-sodium (LY573636) as 2nd-4th line therapy for platinum resistant ovarian cancer
  Gordon M, McMeeking Ds, Temkin s, Tew W, S Yapp, Scambia G, Streltsova O, Kaiser C, Ilaria R Look KY, 39th Annual Meeting on Women's Cancer, Tampa, FL, 3/9/2008
• Randomized Phase II Stuy of Standard versus High Dose Pemetrexed in Platinum-Resistant Epithelial Ovary Cancer (Poster)
  Vergote I, Calvert H, Kania M, Zimmerman A, Look K, Sehouli J., Society Gynecologic Oncolog, 1/1/2008
• Feasibility of Combination IV Carboplatin (AUC 5) and Paclitaxel (175 mg/m2) with oral enastaurin in Advanced Ovarian/Primary Peritoneal Cancer: A Safety Lead-In Study...
  Vergote I, Amant F, Mustea A, Musib L, Michel A, Kania M, Look K, Sehouli J, ESGO, Berlin, Germany, 10/28/2007
• Does the Cell Adhesion Marker E Cadherin Predict for Lymph Node Metastases in Grade 2-3 Endometrial Cancer (Poster)
  Bermeo M, Emerson RE, Bigsby RM, Look KY, 38th Annual Society of Gynecologic Oncologists Annual On Women's Cancer, San Diego, CA, 3/4/2007
• Setting the Mark: Puff Ball Transfer Drill— Assessment of Laparoscopic Visual-Spatial Skills
  Raff G, Young S, Zollinger T, Look KY, Obstetrics & Gynecology Residents, 7/1/2006
• Objective Structured Evaluation of Surgical Skills
  Schroeder HL, Zollinger TW, Look KY, Obstetrics and Gynecology Residents Poster Presentation APGO CREOG, Orlando, FL, 3/1/2006
• Phase II Trial of liposomal doxorubicin disseminated endometrial carcinoma. A Gynecologic Oncology Group study (Poster Discussion)
  Homesley HD, Blessing JA, Sorosky JI, Look KY, 41st Annual Meeting of American Society of Clinical Oncology, Orlando, FL, 5/13/2005
• Two views of obstetrics-gynecology resident satisfaction
  Blazek B, Zollinger TW, Look KY, CREOG and APGO Annual Meeting, Salt Lake City, UT, 1/1/2005
• Phase II Trial of liposomal doxorubicin disseminated endometrial carcinoma. A Gynecologic Oncology Group study
  Homesley HD, Blessing JA, Sorosky JI, Look KY, Proceedings of the American Society of Clinical Oncology, 1/1/2005
• Comparison of Staff and Resident Adherence to the american College of Obstetricians and Gynecologists Screening Tool for hysterectomy for Leiomyomata (Poster Presentat...
  Korzen C, Brizendine E, Look KY, 52nd Annual Meeting of the American College of Obstetrics and Gyencology, Philadelphia, PA, 5/1/2004
• A study at Indiana University School of Medcine to identify factors detracting students from applying for an obstetrics and gynecology residency (Oral Presentation)
  Gariti D, Zollinger TW, Look KY, CREOG and APGO Annual Meeting, Orlando FL, 3/1/2004
• Intraperitoneal Radioactive Phosphorus (32P) and Vaginal Brachytherapy as Adjuvant Treatment for Papillary Serous Carcinoma and Cler Cell Carcinoma: a Phase II Hoosier...
  Fakiris A, Cardenes HR, Moore DH, Reddy S, Look KY, Yiannoutsos CT, Randall ME, Gynecol Oncol, 1/1/2004
• Comparison of Staff and Resident Adherence to the american College of Obstetricians and Gynecologists Screening Tool for hysterectomy for Leiomyomata
  Korzen C, Brizendine E, Look KY, Obstet Gynecol, 1/1/2004
• A Phase II Trial of Gemcitabine in Persistent or Recurrent Uterine Leiomyosarcoma: a Gynecologic Oncology Group Study
  Look KY, Sandler A, Blessing JA, Lucci JA, Rose PG, 34th Annual meeting of the Society of Gynecologic Oncology, New Orleans, LA, 1/31/2003
• A Phase II Trial of Gemcitabine in Persistent or Recurrent Uterine Leiomyosarcoma: a Gynecologic Oncology Group Study
  Look KY, Sandler A, Blessing JA, Lucci JA, Rose PG, Gynecol Oncol, 1/1/2003
• A randomized phase III trial of three vs six cycles of carboplatin and paclitaxel as adjuvant treatment in early stage ovarian epithelial carcinoma: a Gynecologic Onco...
  Bell J, Brady M, Lage J, Look KY, Spirtos N, Walker J, Rose GS, Gynecol Oncol, 1/1/2003
• Randomized trial of doxorubicin (DOX), plus cisplatin (CIS) versus DOX plus CIS plus paclitaxel (TAX) in patients with advanced or recurrent endometrial carcinoma: a G...
  Fleming GF, Brunetto VL, Mundt AJ, Burks Rt, Look KY, 38th Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, 5/18/2002
• Comparison of Survival and Disease-Free Interval in Patients with Dual Primaries of Breast and Epithelial Ovarian Cancer (EOC) vs. Patients with Single Primary EOC (Po...
  Dunlop J,Schilder J, Dearnley D, Hurteau J, Moore DH, Look KY, 33rd Annual Meeting of SGO, Miami, FL, 3/1/2002
• Comparison of Survival and Disease-Free Interval in Patients with Dual Primaries of Breast and Epithelial Ovarian Cancer (EOC) vs. Patients with Single Primary EOC
  Dunlop J,Schilder J, Dearnley D, Hurteau J, Moore DH, Look KY, Gynecol Oncol, 1/1/2002
• Randomized trial of doxorubicin (DOX), plus cisplatin (CIS) versus DOX plus CIS plus paclitaxel (TAX) in patients with advanced or recurrent endometrial carcinoma: a G...
  Fleming GF, Brunetto VL, Mundt AJ, Burks Rt, Look KY, Proceedings of the American Society of Clinical Oncology, 1/1/2002
• An Update of the Phase Feasibility Trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated Epithelial ovarian cancer or primary periton...
  Look KY, Bookman MA, Brady M, Schol J, Herzog T, Rocereto T, 32nd Annual Meeting of SGO, Nashville, TN, 3/1/2001
• Join now to see all

Other

• An Evidence-based Approach to adjuvant therapy for stage I-II endometrial cancer 
  Look KY, Reviews in Gynecologic Practice, Elsevier
  1/1/2002
• New Developments in Ovary Cancer 
  Look KY, Intraperitoneal Chemo therapy Hoosier Oncology Group Vol. 3
  7/1/1990